Parsons Capital Management Inc. RI Has $1.61 Million Position in MiMedx Group, Inc. (NASDAQ:MDXG)

Parsons Capital Management Inc. RI decreased its holdings in shares of MiMedx Group, Inc. (NASDAQ:MDXG) by 12.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 167,149 shares of the company’s stock after selling 23,497 shares during the period. Parsons Capital Management Inc. RI’s holdings in MiMedx Group were worth $1,608,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. SG Americas Securities LLC raised its holdings in shares of MiMedx Group by 79.9% in the 4th quarter. SG Americas Securities LLC now owns 83,385 shares of the company’s stock worth $802,000 after acquiring an additional 37,031 shares during the last quarter. Fiduciary Alliance LLC bought a new stake in MiMedx Group during the 4th quarter worth approximately $160,000. JPMorgan Chase & Co. raised its stake in shares of MiMedx Group by 265.4% in the third quarter. JPMorgan Chase & Co. now owns 297,367 shares of the company’s stock worth $1,757,000 after purchasing an additional 215,995 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of MiMedx Group by 6.3% in the third quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock valued at $328,000 after purchasing an additional 3,292 shares in the last quarter. Finally, SkyView Investment Advisors LLC boosted its position in shares of MiMedx Group by 30.0% during the third quarter. SkyView Investment Advisors LLC now owns 13,000 shares of the company’s stock valued at $77,000 after buying an additional 3,000 shares during the last quarter. 79.15% of the stock is owned by institutional investors.

MiMedx Group Stock Down 0.9 %

MDXG stock opened at $8.71 on Tuesday. The stock has a market cap of $1.28 billion, a P/E ratio of 15.84 and a beta of 1.96. The company has a current ratio of 4.10, a quick ratio of 3.53 and a debt-to-equity ratio of 0.10. The stock’s fifty day simple moving average is $9.20 and its two-hundred day simple moving average is $7.49. MiMedx Group, Inc. has a 1-year low of $5.47 and a 1-year high of $10.14.

MiMedx Group (NASDAQ:MDXG) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.02. The company had revenue of $84.06 million during the quarter, compared to analyst estimates of $81.00 million. MiMedx Group had a net margin of 23.86% and a return on equity of 26.21%. During the same quarter in the prior year, the business earned $0.05 earnings per share. Analysts expect that MiMedx Group, Inc. will post 0.3 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $12.00.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.